105 related articles for article (PubMed ID: 3759574)
1. Interaction of iododeoxyuridine and its primary metabolite, iodouracil on radiation response.
Kinsella TJ; Dobson PP; Mitchell JB
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1519-22. PubMed ID: 3759574
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of incorporated iododeoxyuridine cellular radiosensitization by photon activation therapy.
Miller RW; DeGraff W; Kinsella TJ; Mitchell JB
Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1193-7. PubMed ID: 3610707
[TBL] [Abstract][Full Text] [Related]
3. Modification of potentially lethal damage in irradiated Chinese hamster V79 cells after incorporation of halogenated pyrimidines.
Franken NA; Van Bree CV; Kipp JB; Barendsen GW
Int J Radiat Biol; 1997 Jul; 72(1):101-9. PubMed ID: 9246199
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of 5-iodo-2'-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation.
Klecker RW; Jenkins JF; Kinsella TJ; Fine RL; Strong JM; Collins JM
Clin Pharmacol Ther; 1985 Jul; 38(1):45-51. PubMed ID: 4006375
[TBL] [Abstract][Full Text] [Related]
5. Thermal sensitivity and radiosensitization in V79 cells after BrdUrd or IdUrd incorporation.
Raaphorst GP; Vadasz JA; Azzam EI
Radiat Res; 1984 Apr; 98(1):167-75. PubMed ID: 6718691
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of chemotherapy cytotoxicity following iododeoxyuridine incorporation in Chinese hamster cells.
Russo A; DeGraff W; Kinsella TJ; Gamson J; Glatstein E; Mitchell JB
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1371-4. PubMed ID: 3759557
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme.
Kinsella TJ; Collins J; Rowland J; Klecker R; Wright D; Katz D; Steinberg SM; Glastein E
J Clin Oncol; 1988 May; 6(5):871-9. PubMed ID: 2835444
[TBL] [Abstract][Full Text] [Related]
8. Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancer.
Schilsky RL; Janisch L; Berezin F; Mick R; Vogelzang NJ; Ratain MJ
Cancer Res; 1993 Mar; 53(6):1293-6. PubMed ID: 7680282
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs.
Kinsella TJ; Dobson PP; Mitchell JB; Fornace AJ
Int J Radiat Oncol Biol Phys; 1987 May; 13(5):733-9. PubMed ID: 3570896
[TBL] [Abstract][Full Text] [Related]
10. Iododeoxyuridine radiosensitization of human glioblastoma cells exposed to acute and chronic gamma irradiation: mechanistic implications and clinical relevance.
Schultz CJ; Gaffney DK; Lindstrom MJ; Kinsella TJ
Cancer J Sci Am; 1995; 1(2):151-61. PubMed ID: 9166468
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
[TBL] [Abstract][Full Text] [Related]
12. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation.
Greene RF; Collins JM
Cancer Res; 1990 Oct; 50(20):6652-6. PubMed ID: 2208128
[TBL] [Abstract][Full Text] [Related]
13. Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells.
Kunugi KA; Vazquez-Padua MA; Miller EM; Kinsella TJ
Cancer Res; 1990 Aug; 50(16):4962-7. PubMed ID: 2199032
[TBL] [Abstract][Full Text] [Related]
14. Ataxia telangiectasia cells exhibit the same radiosensitization response by incorporation of BrdUrd or IdUrd as do normal human cells.
Raaphorst GP; Azzam EI; Vadasz JA
Radiat Res; 1985 Sep; 103(3):455-60. PubMed ID: 4034938
[TBL] [Abstract][Full Text] [Related]
15. Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.
McGinn CJ; Kunugi KA; Tutsch KD; Feierabend C; Alberti D; Lindstrom MJ; Wilding G; Arzoomanian RZ; Kinsella TJ
Clin Cancer Res; 1996 Aug; 2(8):1299-305. PubMed ID: 9816300
[TBL] [Abstract][Full Text] [Related]
16. Effects of bleomycin with iododeoxyuridine, 5'-amino-5'-deoxythymidine, and radiation in a human bladder cancer cell line.
Kunugi KA; Lindstrom MJ; Kinsella TJ
Radiat Res; 1993 Aug; 135(2):262-8. PubMed ID: 7690149
[TBL] [Abstract][Full Text] [Related]
17. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
Kinsella TJ; Glennon MC; Kunugi KA; Lindstrom MJ
Clin Cancer Res; 1996 Jun; 2(6):981-9. PubMed ID: 9816259
[TBL] [Abstract][Full Text] [Related]
18. Mutual kinetic interaction between 5-fluorouracil and bromodeoxyuridine or iododeoxyuridine in dogs.
Smith DE; Brenner DE; Knutsen CA; Deremer SJ; Terrio PA; Johnson NJ; Stetson PL; Ensminger WD
Drug Metab Dispos; 1993; 21(2):277-83. PubMed ID: 8097697
[TBL] [Abstract][Full Text] [Related]
19. Iododeoxyuridine incorporation and radiosensitization in three human tumor cell lines.
Uhl V; Phillips TL; Ross GY; Bodell WJ; Rasmussen J
Int J Radiat Oncol Biol Phys; 1992; 22(3):489-94. PubMed ID: 1735685
[TBL] [Abstract][Full Text] [Related]
20. Halogenated pyrimidines as radiosensitizers for high-LET radiation.
Atcher RW; Russo A; DeGraff WG; Moore M; Grdina DJ; Mitchell JB
Radiat Res; 1989 Feb; 117(2):351-5. PubMed ID: 2922478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]